Table 1.
Baseline characteristics
| Controls (n = 25) | Preclinical AD (n = 16) | MCI (n = 16) | AD dementia (n = 25) | |
|---|---|---|---|---|
| Age in years, mean (SD)a | 64.7 (7.0) | 70.5 (6.9) | 65.8 (7.2) | 66.7 (7.8) |
| Sex, female (%) | 12 (48.0%) | 7 (43.8%) | 10 (62.5%) | 10 (39.1%) |
| Education level, median (IQR)b | 6 (5–7) | 6 (5–6) | 6 (5–7) | 5 (4–6) |
| MMSE score, median (IQR) | 30 (28–30) | 29 (27–30) | 26 (25–27) | 22 (19–23) |
| Global 18F-flortaucipir BPND, mean (SD)c | 0.034 (0.085) | 0.082 (0.130) | 0.260 (0.283) | 0.307 (0.349) |
Depicted are mean values (standard deviation, SD) or median with the interquartile range (IQR) where appropriate. AD = Alzheimer’s disease; MCI = mild cognitive impairment; MMSE = Mini-Mental State Examination.
Age at time of MEG measurement.
Education level according to Verhage score.
Volume-weighted mean cortical 18F-flortaucipir BPND over 50 regions of interest.